CLS B — Clinical Laserthermia Systems AB Balance Sheet
0.000.00%
- SEK192.76m
- SEK177.04m
- SEK18.78m
Annual balance sheet for Clinical Laserthermia Systems AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11.9 | 31.2 | 10.6 | 15.3 | 22.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.02 | 5.49 | 8.4 | 4.78 | 6.77 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 20.9 | 42.4 | 24.3 | 27.1 | 38.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.05 | 1.48 | 1.8 | 3.88 | 13.1 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 44.4 | 66.7 | 49.5 | 57.7 | 78.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 30 | 45.5 | 41.6 | 14 | 12.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 30.5 | 44.9 | 40.3 | 12 | 9.84 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 13.9 | 21.8 | 9.22 | 45.8 | 68.7 |
| Total Liabilities & Shareholders' Equity | 44.4 | 66.7 | 49.5 | 57.7 | 78.6 |
| Total Common Shares Outstanding |